Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : ICOS Corporation -- Ignore unavailable to you. Want to Upgrade?

To: SemiBull who wrote (879)	3/25/2002 12:58:45 PM
From: Ian@SI	Read Replies (1) \| Respond to of 1139

From Briefing.com: 12:33 ET ICOS Corp falls on reports of bearish note : We are hearing from traders that ICOS Corp (ICOS 48.99 -2.14) is being pressured by a bearish note issued by Avalon Research. Apparently, firm believes current market-cap overvalues co's product development pipeline and commercial potential. Also feels there could be a significant delay in the approval process for lead product Cialis. Firm said to have a 12-month target of $30 on the name and rates it a Sell. (This information has been provided by Briefing.com sources. We do not receive Avalon research.) ++++++++++++++++ Given Avalon's track record, maybe I'll get my ICOS shares back at firesale prices. Their Sepsis pipeline alone could prove to be very rewarding...